More evidence for benefits of Rapamycin

April, 2010

Another study using a different strain of genetically engineered mice has confirmed the finding that the transplant drug rapamycin prevented cognitive impairment.

A few months ago, I reported on an exciting finding that rapamycin, a drug currently used in transplant patients, improved memory in Alzheimer's mice. Now a different strain of mice (ones engineered to have defects in the genes that make amyloid precursor protein) has also shown improvements in learning and memory, correlated with less damage in brain tissue, after rapamycin treatment lowered levels of amyloid-beta-42. The mice given the drug performed at levels comparable with normal mice.

http://www.eurekalert.org/pub_releases/2010-04/uoth-adt040110.php

Reference:

[190] Spilman, P., Podlutskaya N., Hart M. J., Debnath J., Gorostiza O., Bredesen D., et al.
(2010). Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease.
PLoS ONE. 5(4), e9979 - e9979.

Rapamycin

seniors

treatment

Alzheimers

Related News

Review confirms early diagnosis tool

A survey of more than 100 studies involving PIB-PET, a diagnostic tool that involves injecting a radiotracer called

Dementia rate in extreme elderly population

Data from 330 participants in The 90+ Study, of whom 70% were women, has revealed an overall annual incidence rate of 18.2% for dementia, rising from 12.7% per year in the 90-94 age group, to 21.2% in the 95-99 age group and 40.7% per year in the 100+ age group.

Stress raises risk of mental decline in older diabetics

A study involving over 1000 older men and women (60-75) with type-2 diabetes has found that those with higher levels of the stress hormone cortisol in their blood are more likely to have experienced cognitive decline.

Mediterranean diet may lower risk of brain damage

Following on from studies showing that a Mediterranean-like diet may be associated with a lower risk of Alzheimer's disease and may lengthen survival in people with Alzheimer's, a six-year study of 712 New Yorkers has revealed that those who were most closely following a Mediterranean-like diet

New test to diagnose early stage Alzheimer's disease

A new test has been developed that measures amyloid-beta oligomers in the cerebrospinal fluid, promising a reliable means of early diagnosis.

New Alzheimer's test offers better opportunities for early detection

A computerized self test (CST) has been developed that is 96% accurate in diagnosing Alzheimer’s and

Major depression more than doubles risk of dementia among adults with diabetes

Both diabetes and clinical depression are known to be risk factors for dementia. Now a study that tracked nearly 4000 diabetics over 5 years has found having both increased the risk 2.7-fold.

Mother’s Alzheimer’s greater risk factor than father’s

A brain scanning study using Pittsburgh Compound B, involving 42 healthy indi

Having greater purpose in life associated with reduced Alzheimer's risk

Data from over 900 community-dwelling older adults participating in the Rush Memory and Aging Project has found that greater purpose in life was associated with a substantially reduced risk of developing Alzheimer's disease, as well as a reduced risk of mild cognitive impairment and a slower rat

Factors predicting conversion of mild cognitive impairment to Alzheimer’s identified

An analysis technique using artificial neural networks has revealed that the most important factors for predicting whether amnestic mild cognitive impairment (

Pages